KLF5 and hematocrit: In the population of the case-control study, SNP rs9573096 (C>T) in KLF5 was significantly associated with an increased risk of HT, with an OR (95% CI) of 1.106 (1.009–1.212) in the additive model after adjustment (Table 2).